Clinical Trials

Study Title:
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T Cell Treatment for Relapsed/Refractory Large B Cell Lymphoma or Grade IIIB Follicular Lymphoma

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Brian Hess, at hessbr@musc.edu. Study Coordinator, Antonia Rupert, at ruperta@musc.edu. Trial opened at the following institutions: Medical University of South Carolina